Gasporox Market Risk Adjusted Performance
| GPX Stock | | | SEK 6.58 -0.22 -3.24% |
Gasporox market risk adjusted performance lookup summarizes this and related technical indicators for Gasporox AB. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context. Gasporox has a market cap of 121.79 M, operating margin of -9.38%, ROE of -9.97%. Use
Risk vs Return Analysis to explore allocation context. This includes a position in Gasporox AB within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
Gasporox AB has current Market Risk Adjusted Performance of
-0.13.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.13 | |
| ER[a] | = | Expected return on investing in Gasporox |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Gasporox Market Risk Adjusted Performance Peers Comparison
Gasporox Market Risk Adjusted Performance Relative To Other Indicators
Gasporox AB is rated
below average in market risk adjusted performance relative to competitors. It is currently under evaluation in maximum drawdown relative to competitors .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.